Therapeutic Proteins & Peptides
In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information about therapeutic protein & peptide targets, technologies, pipelines and markets. The range of products covers industry data as well as in-depth strategic assessment and analysis of protein technologies, targets, product profiles, companies, R&D pipelines, deals and financing.
Clav 625 is not recommended as a recreational drug or as a sleeping aid as its effects can lead to serious complications such as drowsiness and addiction. The side effects that prednisone may cause are low blood count, muscle weakness, nausea, loss of appetite, low body evenings temperature, skin rashes, hair loss, swelling of hands and feet, swelling of eyes, and dry mouth, among others. The study also found no significant differences in overall survival for patients treated with tamoxifen or placebo.
This drug contains the active ingredient doxycycline, a natural antibiotic. Generic cialis tadalafil (sildenafil citrate), which is approved by the fda for the treatment of cialis pagamento consegna Kasūr erectile dysfunction (impotence), is the first drug that treats the problem of penile erection. Our site compares different levitra providers and only offers the best prices.
Subscribe to
our newsletters!
Showing all 11 results
- March of 20242023 sales data of originator therapeutic proteins and antibodies, selected biosimilars and other biologic drug modalities (gene & cell therapy, RNA)€ 104.00
- March of 2024Online database of annual global sales of innovator & bioimilar biologics since the year 2007€ 250.00
- On the same day of purchaseThis product provides basic information on immunotherapeutics on the market and in R&D targeting nectin-4€ 200.00
- On the same day of purchaseThis product provides basic information on approved therapeutics and therapy candidates in R&D targeting PSMA.€ 400.00
- On the same day of purchaseThis product provides basic information on drug candidates in research and development targeting CD40 or CD40 ligand€ 300.00
- On the same day of purchaseThis product provides basic information on drug & imaging candidates in R&D targeting Fibroblast Activation Protein (FAP)€ 300.00
- October of 2021Landscape description and analysis of prodrug antibodies and cytokines employing conventional and novel masking technologies from an industry perspective as of October 2021€ 2250.00
- April of 2019This report provides an overview of therapeutic proteins in development for treatment of arginine-dependent tumors or for enzyme replacement therapy.€ 75.00
- March of 2019This Target Pipeline List provides an overview of biologic and chemical entities on the market or in development for treatment of hyperuricemia associated with gout or tumor lysis€ 150.00
- February of 2019This report provides an overview of isolated and recombinant asparaginase enzymes on the market or in development for treatment of leukemia and solid tumors.€ 100.00
- January of 2019This Target Pipeline List provides an overview of biologic and small molecule approaches to raise high density lipoprotein (HDL) for reduction of recurrent cardiovascular events.€ 100.00